8-81529577-A-C

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001105281.6(FABP12):ā€‹c.107T>Gā€‹(p.Leu36Trp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000489 in 1,613,932 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.000013 ( 0 hom., cov: 33)
Exomes š‘“: 0.000053 ( 1 hom. )

Consequence

FABP12
NM_001105281.6 missense

Scores

4
3
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 7.52
Variant links:
Genes affected
FABP12 (HGNC:34524): (fatty acid binding protein 12) Predicted to enable lipid binding activity. Predicted to be located in cytosol. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.14377376).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
FABP12NM_001105281.6 linkuse as main transcriptc.107T>G p.Leu36Trp missense_variant 3/5 NP_001098751.1 A6NFH5
FABP12XM_006716465.4 linkuse as main transcriptc.107T>G p.Leu36Trp missense_variant 3/5 XP_006716528.1 A6NFH5
FABP12XM_011517577.3 linkuse as main transcriptc.107T>G p.Leu36Trp missense_variant 4/6 XP_011515879.1 A6NFH5

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
FABP12ENST00000360464.6 linkuse as main transcriptc.107T>G p.Leu36Trp missense_variant 3/51 ENSP00000353650.4 A6NFH5
FABP12ENST00000692030.1 linkuse as main transcriptc.107T>G p.Leu36Trp missense_variant 4/6 ENSP00000510293.1 A6NFH5
FABP12ENST00000519696.1 linkuse as main transcriptn.59T>G non_coding_transcript_exon_variant 2/45 ENSP00000427973.1 H0YAS1
ENSG00000253374ENST00000523380.5 linkuse as main transcriptn.505+3121A>C intron_variant 5

Frequencies

GnomAD3 genomes
AF:
0.0000131
AC:
2
AN:
152256
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000803
AC:
20
AN:
249036
Hom.:
0
AF XY:
0.000118
AC XY:
16
AN XY:
135084
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000622
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000885
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000527
AC:
77
AN:
1461558
Hom.:
1
Cov.:
31
AF XY:
0.0000770
AC XY:
56
AN XY:
727040
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000812
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000270
Gnomad4 OTH exome
AF:
0.0000663
GnomAD4 genome
AF:
0.0000131
AC:
2
AN:
152374
Hom.:
0
Cov.:
33
AF XY:
0.0000134
AC XY:
1
AN XY:
74520
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000414
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.00000378
ExAC
AF:
0.000141
AC:
17
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJun 06, 2023The c.107T>G (p.L36W) alteration is located in exon 2 (coding exon 2) of the FABP12 gene. This alteration results from a T to G substitution at nucleotide position 107, causing the leucine (L) at amino acid position 36 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.37
CADD
Uncertain
25
DANN
Benign
0.96
DEOGEN2
Benign
0.068
T
Eigen
Pathogenic
0.76
Eigen_PC
Pathogenic
0.70
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.87
D
M_CAP
Benign
0.0044
T
MetaRNN
Benign
0.14
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Pathogenic
3.4
M
PrimateAI
Benign
0.43
T
PROVEAN
Uncertain
-4.3
D
REVEL
Benign
0.20
Sift
Uncertain
0.0020
D
Sift4G
Benign
0.066
T
Polyphen
1.0
D
Vest4
0.53
MutPred
0.36
Gain of catalytic residue at P39 (P = 0.025);
MVP
0.25
MPC
0.056
ClinPred
0.59
D
GERP RS
4.7
Varity_R
0.34
gMVP
0.45

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs369124894; hg19: chr8-82441812; API